BACKGROUND: Hospital-associated infection (HAI) and antimicrobial resistance (AMR) are major health threats in low- and middle-income countries (LMICs). Because diagnostic capacity is lacking throughout most of Africa, patients are commonly managed with prolonged empirical antibiotic therapy. Our goal was to assess mortality in relation to HAI and empirical therapy in Ethiopia's largest referral hospital. METHODS: Cohort study of patients with suspected HAI at Tikur Anbessa Specialized Hospital from October 2016 to October 2018. Blood culture testing was performed on an automated platform. Primary outcomes were proportion of patients with bloodstream infection (BSI), antibiotic resistance patterns and 14 day mortality. We also assessed days of therapy (DOT) pre- and post-blood culture testing. RESULTS: Of 978 enrolled patients, 777 had blood culture testing; 237 (30%) had a BSI. Enterobacteriaceae were isolated in 49%; 81% of these were cephalosporin resistant and 23% were also carbapenem resistant. Mortality at 14 days was 31% and 21% in those with and without BSI, respectively. Ceftriaxone resistance was strongly correlated with mortality. Patients with BSI had longer DOT pre-blood culture testing compared with those without BSI (median DOT 12 versus 3 days, respectively, P < 0.0001). After testing, DOT were comparable between the two groups (20 versus 18 days, respectively). CONCLUSIONS: BSI are frequent and fatal among patients with suspected HAI in Ethiopia. Highly resistant blood isolates are alarmingly common. This study provides evidence that investing in systematic blood culture testing in LMICs identifies patients at highest risk of death and that empirical management is frequently inappropriate. Major investments in laboratory development are critical to achieve better outcomes.
BACKGROUND: Hospital-associated infection (HAI) and antimicrobial resistance (AMR) are major health threats in low- and middle-income countries (LMICs). Because diagnostic capacity is lacking throughout most of Africa, patients are commonly managed with prolonged empirical antibiotic therapy. Our goal was to assess mortality in relation to HAI and empirical therapy in Ethiopia's largest referral hospital. METHODS: Cohort study of patients with suspected HAI at Tikur Anbessa Specialized Hospital from October 2016 to October 2018. Blood culture testing was performed on an automated platform. Primary outcomes were proportion of patients with bloodstream infection (BSI), antibiotic resistance patterns and 14 day mortality. We also assessed days of therapy (DOT) pre- and post-blood culture testing. RESULTS: Of 978 enrolled patients, 777 had blood culture testing; 237 (30%) had a BSI. Enterobacteriaceae were isolated in 49%; 81% of these were cephalosporin resistant and 23% were also carbapenem resistant. Mortality at 14 days was 31% and 21% in those with and without BSI, respectively. Ceftriaxone resistance was strongly correlated with mortality. Patients with BSI had longer DOT pre-blood culture testing compared with those without BSI (median DOT 12 versus 3 days, respectively, P < 0.0001). After testing, DOT were comparable between the two groups (20 versus 18 days, respectively). CONCLUSIONS: BSI are frequent and fatal among patients with suspected HAI in Ethiopia. Highly resistant blood isolates are alarmingly common. This study provides evidence that investing in systematic blood culture testing in LMICs identifies patients at highest risk of death and that empirical management is frequently inappropriate. Major investments in laboratory development are critical to achieve better outcomes.
Authors: Sepideh Bagheri Nejad; Benedetta Allegranzi; Shamsuzzoha B Syed; Benjamin Ellis; Didier Pittet Journal: Bull World Health Organ Date: 2011-07-20 Impact factor: 9.408
Authors: Abigail Fraser; Mical Paul; Nadja Almanasreh; Evelina Tacconelli; Uwe Frank; Roberto Cauda; Sara Borok; Michal Cohen; Steen Andreassen; Anders D Nielsen; Leonard Leibovici Journal: Am J Med Date: 2006-11 Impact factor: 4.965
Authors: Patrick Musicha; Jennifer E Cornick; Naor Bar-Zeev; Neil French; Clemens Masesa; Brigitte Denis; Neil Kennedy; Jane Mallewa; Melita A Gordon; Chisomo L Msefula; Robert S Heyderman; Dean B Everett; Nicholas A Feasey Journal: Lancet Infect Dis Date: 2017-08-14 Impact factor: 25.071
Authors: Eili Y Klein; Thomas P Van Boeckel; Elena M Martinez; Suraj Pant; Sumanth Gandra; Simon A Levin; Herman Goossens; Ramanan Laxminarayan Journal: Proc Natl Acad Sci U S A Date: 2018-03-26 Impact factor: 11.205
Authors: Cherry Lim; Elizabeth A Ashley; Raph L Hamers; Paul Turner; Thomas Kesteman; Samuel Akech; Alejandra Corso; Mayfong Mayxay; Iruka N Okeke; Direk Limmathurotsakul; H Rogier van Doorn Journal: Clin Microbiol Infect Date: 2021-06-07 Impact factor: 13.310
Authors: Emmanuel Bottieau; Lukas Van Duffel; Sayda El Safi; Kanika Deshpande Koirala; Basudha Khanal; Suman Rijal; Narayan Raj Bhattarai; Thong Phe; Kruy Lim; Deby Mukendi; Jean-Roger Lilo Kalo; Pascal Lutumba; Barbara Barbé; Jan Jacobs; Marjan Van Esbroeck; Nikki Foqué; Achilleas Tsoumanis; Philippe Parola; Cedric P Yansouni; Marleen Boelaert; Kristien Verdonck; François Chappuis Journal: BMC Med Date: 2022-05-02 Impact factor: 11.150
Authors: Lukas Van Duffel; Cedric P Yansouni; Jan Jacobs; Marjan Van Esbroeck; Kadrie Ramadan; Jozefien Buyze; Achilleas Tsoumanis; Barbara Barbé; Marleen Boelaert; Kristien Verdonck; Francois Chappuis; Emmanuel Bottieau Journal: Open Forum Infect Dis Date: 2022-08-24 Impact factor: 4.423